Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Chemical Science|October 18, 2024
A simplified and efficient extracellular vesicle-based proteomics strategy for early diagnosis of colorectal cancerJin Zhang, Zhaoya Gao, Weidi Xiao, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
HDAC and MEK inhibition synergistically suppresses HOXC6 and enhances PD-1 blockade efficacy in BRAFV600E-mutant microsatellite stable colorectal cancerZhuang Sun, Mengyuan Shi, Jinhong Xia, et al.
Cancer Letters|September 12, 2025
Improved identification of tumor-specific TCRs from circulating lymphocytes using autologous colorectal tumor organoidsLisha Ma, Xiya Wang, Qianjing Zhang, et al.
Journal for Immunotherapy of Cancer|May 28, 2026
CLEC2B-KLRB1 axis acts as an immune checkpoint, governing the exhaustion of CD8+ T cells and their resistance to immune checkpoint blockadeJie Cheng, Jiahua Lu, Zhaoya Gao, et al.
Medcomm|June 10, 2026
Integrative Proteogenomic Characterization of Left-Sided and Right-Sided Colorectal CancerAn Huang, Haopeng Hong, Yonghui Sun, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2024
Identification and validation of tumor-specific T cell receptors from tumor infiltrating lymphocytes using tumor organoid co-culturesZhilang Li, Lisha Ma, Zhaoya Gao, et al.
Cell Research|July 4, 2025
A patient-derived organoid model captures fetal-like plasticity in colorectal cancerLiang Xiong, Ying Xu, Zhaoya Gao, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 27, 2020
Surgical treatment of massive stoma site tumors after a curative operation for rectal cancerZhaoYa Gao, DaKui Zhang, FuMing Lei, et al.
International Journal of Biological Sciences|December 9, 2025
KRAS-Driven Hypertranscription and Metastatic Dissemination in Colorectal Cancer Could be Overcome by Targeting the NMHC IIA/ PLK1 Signaling Axis with a Novel Acridine DerivativeDengbo Ji, Haizhao Yi, Ming Li, et al.
Frontiers in Immunology|December 3, 2025
IL-12 and GM-CSF engineered dendritic cells enhance the enrichment and selection of tumor-reactive T cells for cancer immunotherapyZhen Liu, Haoyun Li, Zhaoya Gao, et al.
Pageof 4